Dr. Claypool is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4104 Meadow Ln
Newtown Square, PA 19073Phone+1 484-420-4300- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1979 - 1981
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1977 - 1979
- University of MinnesotaInternship, Internal Medicine, 1976 - 1977
- Uconn School Of MedicineClass of 1976
Certifications & Licensure
- PA State Medical License 1978 - 2024
- IL State Medical License 1984 - 1993
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 77 citationsTargeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant Acinetobacter baumannii Both in Vit...Manuka Ghosh, Patricia A. Miller, Ute Möllmann, William D. Claypool, Valerie A. Schroeder, William R. Wolter, Mark A. Suckow, Honglin Yu, Li Shuang, Weiqiang Huang, Ja...> ;Journal of Medicinal Chemistry. 2017 Apr 1
- 48 citationsAugmentation of rat alveolar macrophage migration by surfactant protein.Robert M. Hoffman, William D. Claypool, Sikandar L. Katyal, Gurmukh Singh, Robert M. Rogers, James H. Dauber> ;The American Review of Respiratory Disease. 2015 May 14
- 3 citationsBidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.Richard L. Page, J. Marcus Wharton, William E. Wilkinson, Ina M Friedman, William D Claypool, Aziz Karim, Kenneth G. Kowalski, Shawn J McDonald, Peter Gardiner, Edward...> ;Clinical Pharmacology and Therapeutics. 1992 Apr 1
- Join now to see all
Press Mentions
- Shionogi Enters into a License and Research Collaboration for the Treatment of Mycobacterial Diseases with Hsiri Therapeutics, IncOctober 11th, 2019
- Synthetic Sideromycins (Skepticism and Optimism): Selective Generation of Either Broad or Narrow Spectrum Gram-Negative AntibioticsMarch 27th, 2019
Grant Support
- Nhlbi Clinical Investigator Award ProgramNational Heart, Lung, And Blood Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: